News & Analysis on Clinical Trial Services & Contract Research And Development
A new Frost & Sullivan report predicts the Latin American clinical research market for CROs (contract research organizations) will grow at a pace of 7.1% through 2019, with larger CROs taking advantage of the market the most.
Central lab services provider LabConnect will be moving its operations center in Johnson City, Tenn., to a new 42,000-square-foot custom-built facility effective May 7.
Following a May 2014 inspection, US FDA officials have issued a warning letter with multiple cGMP (current good manufacturing practice) deficiencies for Hospira’s manufacturing facility in Liscate, Italy.
Molecular imaging company Protea Biosciences has acquired CRO vivoPharm in the latest instance of consolidation in the preclinical sector.
Wilmington, North Carolina-based CRO (contract research organization) PPD (Pharmaceutical Product Development) and Tokyo-based Shin Nippon Biomedical Laboratories (SNBL) have closed an agreement to form a joint venture to provide clinical development...
The reputation of Indian clinical trials has been damaged by the “unjustified” suspension of medicines tested by GVK Biosciences, Pharmexcil says as it attacks the evidence submitted by French regulators.
Update
Three Amgen manufacturing sites, along with Pfizer’s Perth, Australia site are part of a list of more than 100 US FDA Form 483s issued so far in 2015, according to a list obtained by In-Pharmatechnologist.com thanks to the FOIA (Freedom of Information...